{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:08:47Z","timestamp":1790791727176,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.burns.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T09:39:58Z","timestamp":1551346798000},"page":"818-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Brendan J.","family":"Cronin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura N.","family":"Godat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-453X","authenticated-orcid":false,"given":"Allison E.","family":"Berndtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha","family":"Kolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Box","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1598-9619","authenticated-orcid":false,"given":"Jeanne G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2019.02.011_bib0005","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/01.TA.0000057149.42968.1D","article-title":"The prevalence of venous thromboembolism of the lower extremity among thermally injured patients determined by duplex sonography","volume":"55","author":"Wibbenmeyer","year":"2003","journal-title":"J Trauma"},{"key":"10.1016\/j.burns.2019.02.011_bib0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.burns.2003.12.019","article-title":"Analysis of deep vein thrombosis in burn patients","volume":"30","author":"Fecher","year":"2004","journal-title":"Burns"},{"key":"10.1016\/j.burns.2019.02.011_bib0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/BCR.0B013E318148C887","article-title":"Practice guidelines for deep venous thrombosis prophylaxis in burns","volume":"28","author":"Faucher","year":"2007","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2019.02.011_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004630-200203000-00005","article-title":"Venous thrombosis incidence in burn patients: preliminary results of a prospective study","volume":"23","author":"Wahl","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2019.02.011_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00005373-200103000-00014","article-title":"Thermally injured patients are at significant risk for thromboembolic complications","volume":"50","author":"Harrington","year":"2001","journal-title":"J Trauma"},{"key":"10.1016\/j.burns.2019.02.011_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/BCR.0b013e318204b2ff","article-title":"Venous thromboembolism in thermally injured patients: analysis of the national burn repository","volume":"32","author":"Pannucci","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2019.02.011_bib0035","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","article-title":"A prospective study of venous thromboembolism after major trauma","volume":"331","author":"Geerts","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.burns.2019.02.011_bib0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TA.0b013e3182788fa7","article-title":"Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients","volume":"74","author":"Costantini","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0049-3848(02)00031-2","article-title":"Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment","volume":"105","author":"Sanderink","year":"2002","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.burns.2019.02.011_bib0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mcp.2002.127114","article-title":"The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers","volume":"72","author":"Sanderink","year":"2002","journal-title":"Clin Pharmacol Therapeutics"},{"key":"10.1016\/j.burns.2019.02.011_bib0055","first-page":"874","article-title":"Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients","volume":"68","author":"Malinoski","year":"2010","journal-title":"J Trauma"},{"key":"10.1016\/j.burns.2019.02.011_bib0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/TA.0000000000001157","article-title":"Does sex matter? Effects on venous thromboembolism risk in screened trauma patients","volume":"81","author":"Berndtson","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/SLA.0b013e3181856241","article-title":"Pathophysiologic response to severe burn injury","volume":"248","author":"Jeschke","year":"2008","journal-title":"Annals Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0034-1398380","article-title":"Hypercoagulability and venous thromboembolism in burn patients","volume":"41","author":"Meizoso","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.burns.2019.02.011_bib0075","first-page":"27","article-title":"Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices","volume":"70","author":"Haut","year":"2011","journal-title":"J Trauma"},{"key":"10.1016\/j.burns.2019.02.011_bib0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/TA.0b013e3182984911","article-title":"Hypercoagulability after burn injury","volume":"75","author":"Van Haren","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004630-200103000-00008","article-title":"Potential risk factors for deep venous thrombosis in burn patients","volume":"22","author":"Wahl","year":"2001","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2019.02.011_bib0090","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TA.0000000000001142","article-title":"If some is good, more is better: an enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis","volume":"81","author":"Berndtson","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/000313481508100923","article-title":"Standard dosing of enoxaparin for venous thromboembolism prophylaxis is not sufficient for most patients within a trauma intensive care unit","volume":"81","author":"Rostas","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0100","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/TA.0000000000001193","article-title":"Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients","volume":"81","author":"Singer","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/1060028016683970","article-title":"Increased enoxaparin dosing for venous thromboembolism prophylaxis in general trauma patients","volume":"51","author":"Walker","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.burns.2019.02.011_bib0110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamasurg.2016.1662","article-title":"Association between enoxaparin dosage adjusted by anti-factor Xa trough level and clinically evident venous thromboembolism after trauma","volume":"151","author":"Ko","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jss.2015.10.028","article-title":"Non-weight-based enoxaparin dosing subtherapeutic in trauma patients","volume":"201","author":"Chapman","year":"2016","journal-title":"J Surg Res"},{"key":"10.1016\/j.burns.2019.02.011_bib0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.2069","article-title":"Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: a Randomized Clinical Trial","volume":"151","author":"Connelly","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.amjsurg.2013.10.005","article-title":"Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?","volume":"206","author":"Kopelman","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/000313481508100625","article-title":"Prospective evaluation of weight-based prophylactic enoxaparin dosing in critically ill trauma patients: adequacy of antiXa levels is improved","volume":"81","author":"Nunez","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0135","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1345\/aph.1Q313","article-title":"Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients","volume":"45","author":"Ludwig","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.burns.2019.02.011_bib0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.amjsurg.2013.07.020","article-title":"Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient","volume":"206","author":"Bickford","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.burns.2019.02.011_bib0145","first-page":"932","article-title":"Surveillance bias and deep vein thrombosis in the national trauma data bank: the more we look, the more we find","volume":"64","author":"Pierce","year":"2008","journal-title":"J Trauma"},{"key":"10.1016\/j.burns.2019.02.011_bib0150","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/jama.2013.280048","article-title":"Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure","volume":"310","author":"Bilimoria","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.burns.2019.02.011_bib0155","first-page":"1","article-title":"Long-term clinical observations and venous functional abnormalities after asymptomatic venous thrombosis following total hip or knee arthroplasty","volume":"27","author":"Francis","year":"1988","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.burns.2019.02.011_bib0160","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1592\/phco.24.17.1793.52344","article-title":"Antifactor Xa levels in four patients with burn injuries who received enoxaparin to prevent venous thromboembolism","volume":"24","author":"Yogaratnam","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.burns.2019.02.011_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BCR.0b013e318204b346","article-title":"Enoxaparin and antifactor Xa levels in acute burn patients","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2019.02.011_bib0170","first-page":"1557","article-title":"Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients","volume":"71","author":"Lin","year":"2011","journal-title":"J Trauma"},{"key":"10.1016\/j.burns.2019.02.011_bib0175","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/BCR.0b013e3182a2a9f8","article-title":"Enoxaparin and antifactor Xa levels in pediatric acute burn patients","volume":"34","author":"Brown","year":"2013","journal-title":"J Burn Care Res"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417918304856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417918304856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T08:11:31Z","timestamp":1759651891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417918304856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0305417918304856"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2019.02.011","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}